Why We Are In “The Platinum Age” of Healthcare Investment
S2:E44 Featuring Dr. David Eifrig
Hosted by Addison Wiggin
After a decade on Wall Street, Dr Eifrig quit to become a doctor. He researched molecular genetics at Duke University and became an eye surgeon. Along the way, helped start a small biotech company, Mirus, that was sold to Roche for $125 million in 2008. Doc forecasts the rise of the platinum age in healthcare economics and how to find great small companies.
Addison Wiggin is an American writer, publisher, and filmmaker. He was the founder of Agora Financial and publisher for 18 years. An acclaimed New York Times best-selling author, his books include: Financial Reckoning Day, Empire of Debt, The Demise of the Dollar, and The Little Book of the Shrinking Dollar. Addison is also the writer and executive producer of the documentary I.O.U.S.A., an exposé on the national debt, shortlisted for an Academy Award in 2008. He lives in Baltimore, Maryland with his family. Addison started his latest project, The Wiggin Sessions, powered by The Essential Investor, in March 2020. He films from a homegrown studio in his basement.
Dr. David Eifrig
Dr. Eifrig started on Wall Street working with several major financial institutions, including Chase Manhattan and Yamaichi (then known as the “Goldman Sachs of Japan”). After a decade, Dr Eifrig quit his senior position to become a doctor. He completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotech company, Mirus, that was sold to Roche for $125 million in 2008.